These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1735852)

  • 21. Pulmonary haemorrhage, surfactant, and low-birthweight babies.
    Rogers D
    Lancet; 1993 Mar; 341(8846):698. PubMed ID: 8095608
    [No Abstract]   [Full Text] [Related]  

  • 22. One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
    Saigal S; Robertson C; Sankaran K; Bingham W; Casiro O; MacMurray B; Whitfield M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S61-7. PubMed ID: 7745513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Group.
    Casiro O; Bingham W; MacMurray B; Whitfield M; Saigal S; Vincer M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S53-60. PubMed ID: 7745512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
    Rogers D
    Arch Dis Child Fetal Neonatal Ed; 1996 Mar; 74(2):F151. PubMed ID: 8777670
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
    Sauve R; Long W; Vincer M; Bard H; Derleth D; Stevenson D; Pauly T; Robertson C
    J Pediatr; 1995 May; 126(5 Pt 2):S75-80. PubMed ID: 7745515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
    J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse experiences in an Exosurf treated group.
    Chatfield SL; Kelly EJ; Dear PR
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F78. PubMed ID: 8117137
    [No Abstract]   [Full Text] [Related]  

  • 31. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary haemorrhage in low-birthweight babies.
    Majeed-Saidan MA; al-Hifzi I; Khan M
    Lancet; 1993 Jan; 341(8837):120. PubMed ID: 8093391
    [No Abstract]   [Full Text] [Related]  

  • 33. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
    Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
    N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
    Frey B; Keller E; Losa M
    Eur J Pediatr; 1999 Jul; 158(7):610. PubMed ID: 10412829
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
    Phibbs CS; Phibbs RH; Wakeley A; Schlueter MA; Sniderman S; Tooley WH
    J Pediatr; 1993 Dec; 123(6):953-62. PubMed ID: 8229530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.